Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Pharmaceutical pricing stories

Nov 5, 2026

Revolution Medicines' pancreatic cancer drug Rasonque posts record launch

Revolution Medicines' RAS inhibitor Rasonque is tracking as the best cancer drug launch in history by early sales metrics, with Wall Street analysts resetting projections upward. Company executives cautioned it is too early to draw firm conclusions.

Nov 5, 2026·3 sources
00
Aug 20, 2026

U.S. employer healthcare costs projected to rise 9.5% in 2027, exceeding $19,000 per employee

Insurance broker Aon forecasts U.S. employer healthcare costs will jump 9.5% in 2027 to over $19,000 per employee on average, driven by increased medical utilization and high-priced drug spending, representing potentially the largest increase in two decades.

Aug 20, 2026·2 sources
00
Aug 14, 2026

Two-thirds of new drugs launched above cost-effectiveness thresholds, ICER reports

A new ICER analysis found that net launch prices for new medicines spiked significantly between 2022 and 2025, with two-thirds of new drugs priced above cost-effectiveness guidelines. About a quarter of drugs launched in the most recent year had annual net prices exceeding $500,000.

Aug 14, 2026·5 sources
00
Aug 11, 2026

England reaches 100,000 hepatitis C treatments as elimination target moves within reach

New data from NHS England shows the country is nearing elimination of hepatitis C as a public health threat, with 80% of known cases cured. The progress is attributed to widespread testing initiatives including A&E blood tests, GP registration screening, and free at-home tests, along with a pioneering NHS drug deal with pharmaceutical companies.

Aug 11, 2026·6 sources
00
Aug 2, 2026

Michigan Supreme Court Clears Path for Attorney General's Investigation into Eli Lilly Insulin Pricing

The Michigan Supreme Court ruled 4-3 on July 31, 2026, overturning two lower court decisions and allowing Attorney General Dana Nessel to proceed with an investigation into Eli Lilly's insulin pricing practices under the Michigan Consumer Protection Act.

Aug 2, 2026·6 sources
00
Jun 19, 2026

U.S. Launches Trade Investigation Into Germany Over Pharmaceutical Pricing Policies

The U.S. Trade Representative has initiated a formal trade investigation into Germany's plan to reduce spending on pharmaceutical products, examining whether the pricing policies are unreasonable or discriminatory. The probe could result in retaliatory tariffs on German goods.

Jun 19, 2026·5 sources
00
Apr 27, 2026

Mark Cuban’s Cost Plus Drugs Targets Employer Health Costs With New Plan

Cost Plus Drugs introduces a new strategy to partner with employers, aiming to lower prescription drug costs through transparent pricing and direct distribution models.

Apr 27, 2026·2 sources
00
Apr 16, 2026

Report Finds Drugmakers Raised Prices Despite Trump Deals

Senate Democrats’ report finds pharmaceutical companies increased prices on hundreds of medications despite prior agreements intended to limit drug cost growth, raising concerns about enforcement and policy effectiveness.

Apr 16, 2026·3 sources
00
Apr 14, 2026

States Drop Medicaid Coverage for GLP-1 Weight-Loss Drugs as Demand Surges

Rising demand and high costs are driving US states to scale back Medicaid coverage for GLP-1 weight-loss drugs, highlighting growing tensions between access, affordability, and public healthcare budgets.

Apr 14, 2026·3 sources
00

Top claims

  • ▪Revolution Medicines reported $198 million in third-quarter 2026 revenue for Rasonque over five weeks following FDA approval, exceeding financial analyst forecasts of $50 million to $100 million
  • ▪Revolution Medicines set a list price of $39,800 for a 30-day supply of Rasonque
  • ▪More than 5,000 patients in the United States received treatment with Rasonque in the five weeks through September 30, 2026

People involved

Donald Trump

Subtopics

Drug Policy, Pricing & Approval6Healthcare Access and Insurance3Healthcare Policy3Medication Pricing & Affordability3Pharma3Public healthcare3US health policy & drug pricing2Antiviral therapy1Cancer & Oncology1Congressional oversight1Cost Plus Drugs1Drug Approval and Clinical Trials1Drug pricing1FDA drug approval1Global trade1GLP-11GLP-1 medications1Government and Regulatory Policy1Health screening1Healthcare costs1Healthcare costs & access disparities1Healthcare fraud & litigation1Infectious disease1Infectious Disease and Outbreaks1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories